FIELD: medicine, endocrinology, pharmacy. SUBSTANCE: invention proposes a solid insulin-containing drug for treatment of patients with diabetes mellitus by oral route of administration. Drug consists of insulin-containing core, protein inhibitor of proteolytic enzymes as a cross-linked hydrophilic polymer modified with ovomucoid, additional substances and envelope exhibiting resistance in stomach. Indicated agent shows stable biological activity for continuous time, hypoglycemic effect (about 60-70% of activity of insulin used for subcutaneous injections at the same doses). EFFECT: enhanced effectiveness of drug. 2 cl, 4 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING INSULIN-CONTAINING POLYMERIC HYDROGEL | 1994 |
|
RU2066551C1 |
POLYPEPTIDE COMPOSITION | 1999 |
|
RU2171687C2 |
INSULIN-CONTAINING DRUG FOR ORAL USING AND METHOD OF ITS PREPARING | 1999 |
|
RU2155602C1 |
METHOD FOR POLYMER HYDROGEL PRODUCTION, CONTAINING PHYSIOLOGICALLY ACTIVE SUBSTANCES | 2007 |
|
RU2342147C1 |
METHOD OF INSULIN DERIVATIVES PREPARING | 1994 |
|
RU2076733C1 |
METHOD FOR PRODUCING INSULIN-CONTAINING COMPOSITION | 2020 |
|
RU2752509C1 |
METHOD OF MEDICINAL AGENT BIOAVAILABILITY INCREASE | 2006 |
|
RU2328309C1 |
METHOD FOR PREPARING INSULIN PREPARATION FOR ORAL USING | 2006 |
|
RU2316339C1 |
PHARMACEUTICAL COMPOSITION AS AN MICROEMULSION WITH BIOLOGICALLY ACTIVE MACROMOLECULAR MATERIAL AND A METHOD OF ITS PREPARING | 1989 |
|
RU2122403C1 |
PHARMACEUTICAL COMPOSITION | 2012 |
|
RU2519099C1 |
Authors
Dates
1998-08-20—Published
1997-07-30—Filed